Vice President, US Marketing

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role:   The Vice President (VP), US Marketing will lead the development and execution of the U.S. marketing strategy for the company’s commercial asset, ivonescimab. As the top U.S. commercial leader for this brand, the SVP will be accountable for all aspects of U.S. marketing, including launch preparation, brand positioning, promotional strategy, digital/omnichannel marketing, HCP and patient engagement, and performance optimization. This is a highly visible and mission-critical role, with a mandate to build a best-in-class brand presence in the U.S. market, shape the organization’s commercial culture, and deliver strong business results.   Role and Responsibilities:   Develop and lead the comprehensive U.S. marketing strategy for ivonescimab ensuring differentiation, strong market uptake, and sustained growth   Build the U.S. brand plan, including positioning, value proposition, messaging, and go-to-market strategy across channels and stakeholders   Own and drive U.S. launch readiness, including development of HCP and patient campaigns, sales force enablement, and market shaping activities.   Establish KPIs and performance metrics to guide execution and optimize impact pre- and post-launch   Builds and develops a high-performing, top-tier marketing team to execute strategic initiatives   Foster a culture of agility, accountability, innovation, and collaboration.   Collaborates cross-functionally to ensure alignment and seamless execution of strategic and tactical plans   Oversees investment planning and budget management to maximize brand growth and return on investment   Translates insights from market research, key opinion leader (KOL) engagement, and external stakeholders into actionable business opportunities   Aligns the organization around brand priorities and key growth opportunities, while proactively planning for potential competitive challenges   Owns and validates the brand’s revenue forecast, incorporating risk assessments and opportunity analyses   Drives innovation and adapts strategies to succeed in today’s dynamic launch and commercialization landscape   All other duties as assigned   Experience, Education and Specialized Knowledge and Skills:   Advanced degree in Business, Marketing, Life Sciences, or a related field (MBA, MS, or PhD preferred)   Minimum of 15+ years of progressive experience in pharmaceutical marketing, with at least 7+ years in senior leadership roles   Demonstrated success in leading U.S. launch and/or commercialization of a specialty or first-in-class therapy   Must have recent launch experience; a large-scale brand with multiple competitors is a plus   Must have experience and understanding of U.S. market including key drivers and barriers; global experience is a plus   Proven track record of successfully commercializing Oncology pharmaceutical products, including immuno-oncology (I-O) experiences   Broad background across solid tumors is required; oncology lung experience is a plus   Sales experience, in addition to marketing, is a plus   Need to demonstrate understanding of innovative approaches to launches including digital marketing, SEO optimization, use of ML and AI for no see customers and just in time patients etc.   Keen grasp of the U.S. Oncology customer landscape, working with access and medical to ensure proper access and use of product   Understanding of compliance standards and acting within those standards   Demonstrated leadership, teamwork & team building and cross-functional collaboration   Must have drive, energy, persuasion, imagination, adaptability and versatility   Exceptional leadership, communication, and influencing skills   Analytical mindset with the ability to translate insights into impactful strategy   This is the pay for this position Pay Transparency $315,000 — $350,000 USD   Actual compensation packages are based on several factors that are unique to each candidate